They successfully differentiated four tumor subtypes (Luminal A, Luminal B, HER2-enriched, and triple-negative) by extracting intra- and peri-tumoral features from dynamic contrast-enhanced sequences using radiomics analysis. The gene discussed is ERBB2; the disease is neoplasm.